CytoDyn Market Cap

CytoDyn has a market cap or net worth of $325.38 million as of August 14, 2025. Its market cap has increased by 116.02% in one year.

Market Cap

325.38M

Enterprise Value

340.82M

Revenue

n/a

Ranking

n/a

PE Ratio

142.69

Stock Price

$0.25

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 325.38M, an increase of 5,775.95%. That is a compound annual growth rate of 22.91%.

Market Cap History

Date	Market Cap	% Change
Aug 12, 2025	300.87M	123.48%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.72M
Veradigm	789.71M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	608.19M
Glass House Brands	543.74M
American Oncology Network	393.37M
Northwest Biotherapeutics	332.06M
Alterola Biotech	296.25M

Market Cap Rankings